Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib

被引：0
|
作者：
F. Platini
S. Cavalieri
S. Alfieri
C. Bergamini
C. Resteghini
A. Bottiglieri
E. Colombo
L. Mazzeo
L. Licitra
B. Paolini
E. Seregni
L. D. Locati
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori,Head and Neck Cancer Medical Oncology Unit
[2] University of Milan,Medical Oncology Department
[3] Fondazione IRCCS Istituto Nazionale dei Tumori,Pathology Department
[4] Fondazione IRCCS Istituto Nazionale dei Tumori,Struttura di Terapia Medico Nucleare ed Endocrinologia U.O. Medicina Nucleare
来源：
Endocrine | 2021年 / 73卷
关键词：
Thyroid cancer; RAI-resistant; Lenvatinib; Late toxicities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：641 / 647
页数：6
相关论文
共 50 条
  • [1] Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
    Platini, F.
    Cavalieri, S.
    Alfieri, S.
    Bergamini, C.
    Resteghini, C.
    Bottiglieri, A.
    Colombo, E.
    Mazzeo, L.
    Licitra, L.
    Paolini, B.
    Seregni, E.
    Locati, L. D.
    [J]. ENDOCRINE, 2021, 73 (03) : 641 - 647
  • [2] Lenvatinib - A multikinase inhibitor for radioiodine-refractory differentiated thyroid cancer
    Hewett, Yvonne
    Ghimire, Subash
    Farooqi, Bilal
    Shah, Binay K.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (01) : 28 - 32
  • [3] Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life
    Marotta, Vincenzo
    Rocco, Domenico
    Crocco, Anna
    Deiana, Maria Grazia
    Martinelli, Ruggero
    Di Gennaro, Francesca
    Valeriani, Mariafelicia
    Valvano, Luca
    Caleo, Alessia
    Pezzullo, Luciano
    Faggiano, Antongiulio
    Vitale, Mario
    Monti, Salvatore
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10): : 2541 - 2552
  • [4] Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
    Kiyota, Naomi
    Robinson, Bruce
    Shah, Manisha
    Hoff, Ana O.
    Taylor, Matthew H.
    Li, Di
    Dutcus, Corina E.
    Lee, Eun Kyung
    Kim, Sung-Bae
    Tahara, Makoto
    [J]. THYROID, 2017, 27 (09) : 1135 - 1141
  • [5] Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
    Suzuki, Chiaki
    Kiyota, Naomi
    Imamura, Yoshinori
    Goto, Hideaki
    Suto, Hirotaka
    Chayahara, Naoko
    Toyoda, Masanori
    Ito, Yasuhiro
    Miya, Akihiro
    Miyauchi, Akira
    Teshima, Masanori
    Otsuki, Naoki
    Nibu, Ken-ichi
    Minami, Hironobu
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Baseline Tumour Size as a Prognostic Factor for Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib
    Fukuda, Naoki
    Toda, Kazuhisa
    Ohmoto, Akihiro
    Wang, Xiaofei
    Hayashi, Naomi
    Urasaki, Tetsuya
    Sato, Yasuyoshi
    Nakano, Kenji
    Ono, Makiko
    Tomomatsu, Junichi
    Mitani, Hiroki
    Takahashi, Shunji
    [J]. ANTICANCER RESEARCH, 2021, 41 (03) : 1683 - 1691
  • [7] Late renal toxicity in patient with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib: A case report and literature review
    Pham, Bryan
    Kwon, Sue Min
    Castillo, Dan Ran
    Majeed, Yasamin
    Ahmad, Sarmad
    Hou, Jean
    Ganesan, Lakshmi
    Mohammad, Sharif
    Cao, Huynh
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1930 - 1935
  • [8] Lenvatinib in Radioiodine-Refractory Thyroid Cancer REPLY
    Schlumberger, Martin
    Tahara, Makoto
    Wirth, Lori J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19): : 1868 - 1868
  • [9] Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer
    Suzuki, Chiaki
    Kiyota, Naomi
    Imamura, Yoshinori
    Goto, Hideaki
    Suto, Hirotaka
    Chayahara, Naoko
    Toyoda, Masanori
    Ito, Yasuhiro
    Miya, Akihiro
    Miyauchi, Akira
    Otsuki, Naoki
    Nibu, Ken-ichi
    Minami, Hironobu
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (09): : 3023 - 3032
  • [10] Tumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer
    Leboulleux, S.
    Lee, E. K.
    Bastholt, L.
    Tahara, M.
    Wirth, L. J.
    Sherman, S. I.
    Robinson, B. G.
    Teng, A.
    Joshi, P.
    Misir, S.
    Dutcus, C. E.
    Tuttle, R. M.
    Schlumberger, M. J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345